🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Representing Surgery Glasgow Royal Infirmary at @ACPGBI annual meeting in #Newport With Mr Stevens... Mentor, supervisor and top boss

Really nice to finally attend my PhD graduation just over 3 years after my viva (COVID grrr). My kids seemed to enjoy themselves or was that the bribery ice-cream. One of life's eternal mysteries. Surgery Glasgow Royal Infirmary Donald McMillan Barry Laird UofG MVLS Caledonian Cachexia Collaborative

Short Course-based TNT with immunotherapy demonstrates impressive complete response rates in this landmark #rectalcancer trial The PRIME-RT trial compares SC and LC-based TNT with Durvalumab. Looking forward to sharing our results very soon! RadNetCRUKGlasgow UofG Cancer Sciences

Massive congratulations to the awesome Natalie Fisher 🏆 Natalie has led our Science and Innovation at Cancer Research UK #EarlyDetection work in Belfast over the last few years, and now deploying her approach within INCISE across our Glasgow networks.

An outstanding visit to Surgery Glasgow Royal Infirmary from MD Anderson Cancer Center #surgicalonc Michael White and Neal Bhutani providing insight into advanced #colorectalcancer Mx Congratulations to our research fellows/ surgical trainees for great presentations University of Glasgow UofG MVLS Jamieson Spatial Lab

Spot our Clinical Lead Stephen McSorley and Clinical Research Fellow Mark Johnstone among the participants! 👀

🚨 We are hiring! Gd 7 PDRA position to support research on new AI-based classifiers of RT response in #rectalcancer👇 my.corehr.com/pls/uogrecruit… Funded by Stand Up to Cancer campaign for CRUK - please get in touch!

🌟Big news from GTRF! 🌟We’re excited to welcome our new 3DHISTECH LTD. P1000 scanner, made possible by Beatson Cancer Charity funding! This advanced technology will enhance histology imaging for cancer research. Huge thanks to Edwards Lab for their support! 💙 #Technology #CancerResearch

Excellent lightning talk from PhD student Sara International Conference on Cancer Prevention DKFZ, reporting future adenoma risk prediction using IHC in screen detected polyps from the INCISE cohort Edwards Lab UofG MVLS

Our paper open access in roypounder.apt - socioeconomic deprivation is important for both post polypectomy surveillance uptake and outcomes INCISE UofG MVLS Surgery Glasgow Royal Infirmary NHS Greater Glasgow and Clyde

.Katie Robb and Stephen McSorley are grateful to receive funding from Bowel Cancer UK to investigate barriers to surveillance colonoscopy faced by people in areas with more deprivation.

We are delighted and proud that our final year PhD student Sara was named Runner-up for best final year oral presentation at the Medical Research Scotland Researcher Development Event 🎉 🥳

Thanks to everyone who came out to launch Paperboy last night! Huge thanks to Cailean Steed 🏳️‍⚧️ for chairing and to my mum for the insane cake!

Everything on The Times and The Sunday Times website is free to read today if you fancy a read of my recent interview with Robbie Millen. thetimes.com/culture/books/…

Emma had a great time presenting at the #PublicInvolvement event that was held by NHS Research Scotland last week! Its amazing how medical research is evolving to include patients and the public in the conversation! 🤩

With 5 distinct research groups led by Joanne Edwards, Campbell Roxburgh, Nigel B. Jamieson, Colin W Steele, and Stephen McSorley, IMPACT provides an infrastructure for human tissue-based translational research in Glasgow, in collaboration with Philip Dunne and Xiao Fu! 🤝

Members of IMPACT span wet-lab scientists, pathologists, bioinformaticians, patient involvement managers, image analysts, technicians, clinicians, students, project managers, and lecturers among others, to ensure a wide range of expertise and optimum resource management!

An absolutely brilliant few days in sunny Loch Lomond with my Glasgow colleagues 🏴󠁧󠁢󠁳󠁣󠁴󠁿☘️☀️

🇬🇧PRIME-RT results ESTRO today: Durvalumab anti-PDL1+SC/LC TNT in #rectalcancer 52% of pts had CR (pCR/cCR) @ 6mth post-EOT in LARC ⬆️CR rate w SCRT-Durv - may reflect divergent immune effects of RT on TME Privileged to be part of incredible ‘Top trials’ session#ESTRO25

The PRIME-RT team comprises fantastic clinical/ CTU teams from across the UK - University of Aberdeen, Oxford The Christie NHS, NHS Ayrshire & Arran and University of Glasgow UofG Cancer Sciences Queen's University Belfast 🎓 We are especially appreciative of the patients who contributed time and energy to be part of the trial.